Description

INX-SM-6 can be used for targeted delivery of anti-inflammatory agent. INX-SM-6 inhibits LPS-induced IL-1β production in human PBMCS[1].–20°C (Powder, sealed storage, away from moisture and light)-Applications-COVID-19-immunoregulation-Formula-C32H36N2O6S-Citation–References-[1]Jay ROTHSTEIN, et al. Anti-human vista antibodies and use thereof. WO2021216913A1-CASNumber-2734878-16-9-MolecularWeight-576.70-Compound Purity-98.85-SMILES-O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@H]5O)(O[C@@](C(S6)=CN=C6CC7=CC(N)=CC=C7)([H])O1)[C@]2(C5)C)CO-Research_Area-Inflammation/Immunology-Solubility-DMSO : ≥ 50 mg/mL-Target-ADC Cytotoxin-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related